Location History:
- Redwood City, CA (US) (2015)
- Mountain View, CA (US) (2012 - 2018)
Company Filing History:
Years Active: 2012-2024
Title: **The Innovations of Inventor Li-Sheng Lu**
Introduction
Li-Sheng Lu, based in Mountain View, CA, is a prominent inventor known for his significant contributions to the field of biomedical research and antibody development. With a remarkable portfolio of 10 patents, Lu's innovative work has greatly impacted cancer treatment and therapeutic technologies.
Latest Patents
Among his latest patents is the development of **Anti-CD27 antibodies and uses thereof**, which provides isolated antibodies that bind specifically to CD27 with high affinity. This patent presents methods for treating subjects afflicted with cancer through the administration of a therapeutically effective amount of an anti-CD27 antibody. This treatment can be applied as monotherapy or in combination with checkpoint inhibitors, such as anti-PD-1, anti-PD-L1, or anti-CTLA-4 antibodies. Another notable patent is focused on **human monoclonal antibodies to O8E**, detailing isolated monoclonal antibodies that specifically bind to O8E with high affinity. This disclosure includes nucleic acid molecules encoding the antibodies, expression vectors, host cells, and methods for expressing these antibodies, as well as immunoconjugates, bispecific molecules, and pharmaceutical compositions comprising these antibodies aimed at treating cancer.
Career Highlights
Li-Sheng Lu's impressive career includes significant roles at well-respected companies such as E.R. Squibb & Sons, L.L.C. and Medarex Inc. His innovative mindset has enabled him to hold pivotal positions where he developed ground-breaking antibody therapies.
Collaborations
Throughout his career, Lu has collaborated with talented individuals such as Haichun Huang and Chin Pan. These partnerships have helped propel his inventions and research endeavors, thereby enhancing the impact of his work in the field.
Conclusion
Li-Sheng Lu represents a key figure in the world of biomedical innovations through his groundbreaking patents and collaborative efforts. His contributions to antibody development, particularly in the fight against cancer, continue to pave the way for advancements in therapeutic strategies.